Leap Investments’s Alkermes ALKS Stock Holding History

Leap Investments’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-73,500	Closed	-$1.5M	–	356
2019 Q4	$1.5M	Buy	+73,500	New	+$1.46M	0.7%	24

Other funds holding ALKS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Leap Investments's ALKS Position: Q1 2020 in Review

Leap Investments sold out of Alkermes (ALKS) in Q1 2020, closing a stake of 73,500 shares — an estimated $1.5M sold.

Leap Investments first reported a position in ALKS in Q4 2019 and held it in 1 quarter. The position peaked at $1.5M in Q4 2019. 196 funds tracked by Wall St. Rank hold ALKS as of Q1 2020.

Leap Investments reported no remaining Alkermes position as of Q1 2020 after selling out during the quarter.
Leap Investments sold 73,500 Alkermes shares in Q1 2020, an estimated $1.5M.
Leap Investments first reported a position in Alkermes in Q4 2019 and held it in 1 quarter.
Leap Investments's Alkermes position peaked at $1.5M in Q4 2019.
196 funds tracked by Wall St. Rank held Alkermes as of Q1 2020.

Based on Leap Investments's 13F filing for Q1 2020, filed 15 May 2020.